Clinical Profile of Eprosartan: A Different Angiotensin II Receptor Blocker

E-ISSN： 1875-6182|6|4|253-257

ISSN： 1871-5257

Source： Cardiovascular & Hematological Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Cardiovascular & Hematological Agents), Vol.6, Iss.4, 2008-10, pp. : 253-257

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Angiotensin II receptor blocker combinations: From guidelines to clinical practice

By Narkiewicz Krzysztof

Blood Pressure, Vol. 21, Iss. 2, 2012-04 ,pp. : 73-81

Informa Healthcare

Access to resources Recommend Favorite

A Novel Molecule of the Angiotensin II Receptor Blocker Class: Focus on Olmesartan Medoxomil

By Volpe Massimo

High Blood Pressure & Cardiovascular Prevention, Vol. 12, Iss. 2, 2005-01 ,pp. : 79-89

Adis International

Access to resources Recommend Favorite

Angiotensin II Receptor Blocker as an Inverse Agonist: A Current Perspective

Current Hypertension Reviews, Vol. 1, Iss. 2, 2005-06 ,pp. : 115-121

Bentham Science Publishers

Access to resources Recommend Favorite

Beneficial Effect of Combination Therapy Comprising Angiotensin II Receptor Blocker Plus Calcium Channel Blocker on Plasma Adiponectin Levels

By Inoue Yukiko Kakuma Tatsuyuki Nonaka Yoshisuke Sumi Shunichiro Okamura Keisuke Kodama Sunao Ando Chie Niimura Hideya Miyoshi Kei Tsuchiya Yoshihiro Yamanouchi Yoshio Urata Hidenori

Clinical and Experimental Hypertension, Vol. 32, Iss. 1, 2010-02 ,pp. : 21-28

Informa Healthcare

Access to resources Recommend Favorite

What is the association of acute renal failure, angiotensin-converting enzyme inhibitor and angiotensin II receptor blocker in a young patient?

By Yüksel Selçuk Koçyiğit Ali Uzun Ebru Tepeli Emre Özcan Vefa Becerir Tülay

Clinical Kidney Journal, Vol. 6, Iss. 1, 2013-02 ,pp. : 98-99

Oxford University Press

Access to resources Recommend Favorite